Scrambler Therapy® - Scientific article with the analysis of 3432 cases of chronic neuropathic and oncological pain
This indexed article studies the effects of Scrambler Therapy® on a total of 3432 cases of chronic neuropathic and oncologic pain. The article examines the Scrambler Therapy® theory, method, technology and bias effects in clinical trials and how to minimize them.
This article is especially useful for:
- Health care authorities that have to assess the specific and unique characteristics of the device.
- Health-care insurance companies considering to add the treatment in the cost exemption programs for patients.
-Independent clinical researchers who wish to conduct methodologically correct studies with minimal bias.
- Physicians who want to make the best use of Scrambler Therapy®
The article can be freely downloaded from:https://journals.sagepub.com/doi/10.1177/1534735419845143
About Integrative Cancer Therapies
Integrative Cancer Therapies (ICT) is a peer-reviewed open access journal accepted into the Science Citation Index, SCOPUS, MEDLINE, and is a member of COPE.
About Delta International Service & Logistics (DIS&L)
DIS&L is an agency created for the international development of Scrambler Therapy® Technology (international patent), and selecting of medical device distributors in all international area. DIS&L through its law firm is the only company authorized to sign international exclusive agreements, provide maintenance and distributor support for method usage training and other logistics needs.
More info: https://www.st-team.eu
About Scrambler Therapy® Technology
Scrambler Therapy® scientific research and development technology have been developed in Italy by Professor Giuseppe Marineo, who is the sole owner of its intellectual property rights.
The official "Scrambler Therapy"® scientific and clinical information website is at https://www.scramblertherapy.org/english.htm
Mariella Giorgieri
Delta International Services & Logistics s.r.l.
+39 3921603399
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
